Trade-Ideas: Taser International (TASR) Is Today's Post-Market Leader Stock

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified Taser International ( TASR) as a post-market leader candidate. In addition to specific proprietary factors, Trade-Ideas identified Taser International as such a stock due to the following factors:

  • TASR has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $55.8 million.
  • TASR is up 4.8% today from today's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in TASR with the Ticky from Trade-Ideas. See the FREE profile for TASR NOW at Trade-Ideas

More details on TASR:

TASER International, Inc. is engaged in the development, manufacture, and sale of conducted electrical weapons (CEWs) for use in law enforcement, federal, military, corrections, private security, and personal defense markets worldwide. TASR has a PE ratio of 53.1. Currently there are 3 analysts that rate Taser International a buy, no analysts rate it a sell, and 1 rates it a hold.

The average volume for Taser International has been 1.5 million shares per day over the past 30 days. Taser International has a market cap of $921.4 million and is part of the industrial goods sector and aerospace/defense industry. The stock has a beta of -0.04 and a short float of 7% with 0.80 days to cover. Shares are up 5.4% year-to-date as of the close of trading on Wednesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Fed Crashes the Party: Cramer's 'Mad Money' Recap (Wednesday 4/5/17)

Axon Is Offering Free Body Cameras to Police Officers

Axon Stock Rising, Offers Free Body Camera to U.S. Police

Axon Enterprise Stock Rising on 'Big News' From CEO Smith

Taser, AMD, Amgen, Old Republic :'Mad Money' Lightning Round (3/30/17)